Results 21 to 30 of about 475,340 (247)

Optimal allocation of scarce PCR tests during the COVID-19 pandemic.

open access: yesPLoS ONE, 2023
Background/aimDuring the coronavirus disease (COVID-19) pandemic, Germany and various other countries experienced a shortage of polymerase chain reaction (PCR) laboratory tests due to the highly transmissible SARS-CoV-2 Omicron variant that drove an ...
Afschin Gandjour
doaj   +1 more source

THE ASSESSMENT OF PRETEST PROBABILITY IN OBSTRUCTIVE CORONARY LESION DIAGNOSTICS: UNRESOLVED ISSUES

open access: yesРоссийский кардиологический журнал, 2017
Invasive coronary arteriography is a gold standard in CHD diagnostics, however in many cases it ends with none significant obstructive lesions revealed.
A. N. Sumin
doaj   +1 more source

Statistical approach to mediastinal staging in NSCLC with M.E.S.S.i.a. software

open access: yesMonaldi Archives for Chest Disease, 2019
The exclusion of pathological involvement of mediastinal lymph nodes in patients affected by NSCLC plays a central role in assessing  their prognosis and operability. Ceron et al.
Thomas Galasso   +4 more
doaj   +1 more source

Hay que saber lo que se pide. Lectura crítica de estudios sobre pruebas diagnósticas.

open access: yesRevista Electrónica de AnestesiaR, 2019
La potencia de una prueba diagnóstica se valora mediante su capacidad para discriminar sanos y enfermos, así como en los cambios de la probabilidad previa de presentar la enfermedad según el resultado de la prueba.
Manuel Molina
doaj   +1 more source

Diagnostic value of the modified Duke criteria in suspected infective endocarditis —The PRO-ENDOCARDITIS study

open access: yesInternational Journal of Infectious Diseases, 2021
Objectives: To determine whether relevant comorbidities stratify patients with and without IE and whether these may improve the diagnostic accuracy, in addition to the modified Duke criteria.
Amir A. Mahabadi   +7 more
doaj   +1 more source

Clinical experience and pre-test probability scores in the diagnosis of pulmonary embolism [PDF]

open access: yesQJM, 2003
The Geneva and Wells pre-test probability scores are intended to replace empirical assessment of patients with suspected pulmonary embolism (PE). The effect of clinical experience on the inter-rater variability of these scores, and on empirical judgement, is unknown.To determine whether medical staff appointment grade affects the inter-rater ...
S, Iles   +6 more
openaire   +2 more sources

Use of coronary computed tomography angiography in clinical practice – single centre experience in Switzerland in light of current recommendations based on pretest probability considerations

open access: yesSwiss Medical Weekly, 2019
AIMS OF THE STUDY Coronary computed tomography angiography (CCTA) is recommended as a first-line option for the exclusion of coronary artery disease in patients with low to intermediate (15–50%) pretest probability.
Evelyne Neurauter   +6 more
doaj   +1 more source

Usefulness of a Novel Electrocardiographic Score to Estimate the Pre-Test Probability of Acute Pulmonary Embolism [PDF]

open access: yesThe American Journal of Cardiology, 2020
According to our experience the 12-lead electrocardiogram (ECG) may be used to estimate the pretest probability of acute pulmonary embolism (acPE). To this end, we devised a novel ECG score (nECGs) composed of 5 known ECG criteria, best characterizing the key pathogenetic steps of acPE. A retrospective derivation cohort including 136 patients with acPE
András Vereckei   +9 more
openaire   +2 more sources

Yield of elective coronary angiography; gender differences, patient history, risk factors and angiographic findings in a primary care population

open access: yesScandinavian Journal of Primary Health Care, 2020
Objective To assess yield of elective coronary angiography and gender differences in primary care patients suspected to have stable coronary artery disease (SCAD).
Pieta Sundqvist   +4 more
doaj   +1 more source

Clinical and laboratory markers of the pre-test probability of inflammatory bowel diseases

open access: yesKoloproktologia, 2023
AIM: to distinguish clinical and laboratory markers that could help to diagnose irritable bowel syndrome (IBS) and forms of inflammatory bowel diseases (IBD) — Crohn`s disease (CD) and ulcerative colitis (UC), before colonoscopy.PATIENTS AND METHODS: the retrospective study included 712 patients (CD — 39.2%, UC — 37.8%, IBS — 23%). Clinical (complaints,
I. A. Rasmagina   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy